Kimia Biosciences Ltd
NSE: BSE: 530313
₹33.69
(0%)
Wed, 04 Mar 2026, 08:46 pm
Market Cap1.59B
PE Ratio17.61
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KKimia Biosciences Financials
| Particulars | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 64.46M | 17.47M | 1.92M | 14.60M | 588.65M | 939.17M | 1.07B | 1.33B | 1.25B | 1.28B | 1.04B | 1.18B |
| Gross profit | -314.43K | -20.74M | -27.51M | -4.18M | 62.76M | 92.98M | 93.17M | 117.64M | 48.57M | 21.17M | 34.84M | 236.86M |
| Operating expenses (excl. COGS) | -7.11M | -2.79M | -9.22M | -7.54M | -22.34M | -46.35M | -52.39M | -52.96M | -73.71M | -92.68M | -77.18M | -72.93M |
| Selling/general/admin expenses, total | -6.83M | -2.57M | -8.55M | -4.03M | -20.07M | -42.88M | -50.82M | -52.34M | -72.76M | -91.53M | -76.99M | -71.28M |
| Research & development | — | — | — | — | — | -28.42M | -41.82M | -61.60M | -63.79M | — | -50.19M | — |
| Selling/general/admin expenses, other | -6.83M | -2.57M | -8.55M | -4.03M | -20.07M | -14.46M | -9.00M | 9.26M | -8.97M | -91.53M | -26.81M | -71.28M |
| Other operating expenses, total | -285.17K | -220.51K | -666.28K | -3.52M | -2.26M | -3.48M | -1.58M | -616.00K | -944.00K | -1.15M | -184.00K | -1.64M |
| Operating income | -7.43M | -23.54M | -36.73M | -11.72M | 40.42M | 46.62M | 40.78M | 64.68M | -25.14M | -71.51M | -42.33M | 163.94M |
| Non-operating income, total | -495.54K | 6.56M | -3.70M | 1.67M | 142.00K | -8.56M | -28.52M | -9.34M | -25.04M | -52.37M | -29.50M | -27.60M |
| Interest expense, net of interest capitalized | -844.38K | -404.46K | -5.57M | -2.69M | -1.99M | -19.96M | -25.29M | -33.90M | -36.41M | -42.45M | -45.70M | -40.34M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 1.24M | 2.29M | 3.59M | 854.00K | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 348.84K | 2.24M | 759.16K | 4.36M | 1.94M | 11.24M | -3.47M | 24.13M | 11.35M | 529.00K | 12.58M | 12.75M |
| Non-operating interest income | 17.01K | 19.60K | 24.10K | 19.00K | 669.00K | 12.71M | 650.00K | 536.00K | 311.00K | 293.00K | 325.00K | 218.00K |
| Miscellaneous non-operating expense | 331.83K | 2.22M | 735.06K | 4.34M | 1.27M | -1.47M | -4.12M | 23.60M | 11.04M | 236.00K | 12.26M | 12.53M |
| Unusual income/expense | 0 | 4.73M | 1.11M | 0 | 191.00K | 158.00K | 241.00K | 428.00K | 20.00K | -10.45M | 3.62M | 0 |
| Pretax income | -7.92M | -16.98M | -40.44M | -10.06M | 40.56M | 38.06M | 12.26M | 55.34M | -50.18M | -123.88M | -71.84M | 136.34M |
| Taxes | 77.19K | -52.33K | -91.94K | 761.00K | 0 | 493.00K | 1.55M | -4.30M | 13.15M | 30.36M | 18.75M | -40.22M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -7.85M | -17.03M | -40.53M | -9.29M | 40.56M | 38.55M | 13.81M | 51.04M | -37.03M | -93.52M | -53.09M | 96.12M |
| Net income | -7.85M | -17.03M | -40.53M | -9.29M | 40.56M | 38.55M | 13.81M | 51.04M | -37.03M | -93.52M | -53.09M | 96.12M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 40.00K | 40.00K | — | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -7.85M | -17.03M | -40.53M | -9.29M | 40.52M | 38.51M | 13.81M | 51.04M | -37.03M | -93.52M | -53.09M | 96.12M |
| Basic earnings per share (Basic EPS) | -1.06 | -2.31 | -5.49 | -1.26 | 5.49 | 2.64 | 0.33 | 1.08 | -0.78 | -1.98 | -1.12 | 2.03 |
| Diluted earnings per share (Diluted EPS) | -1.06 | -2.31 | -5.49 | -1.26 | 5.42 | 1.39 | 0.29 | 1.08 | -0.78 | -1.98 | -1.12 | 2.03 |
| EBITDA | -2.96M | -19.18M | -33.80M | -8.25M | 46.16M | 57.60M | 57.38M | 83.79M | 4.27M | -38.19M | -9.41M | 197.73M |
| EBIT | -7.43M | -23.54M | -36.73M | -11.72M | 40.42M | 46.62M | 40.78M | 64.68M | -25.14M | -71.51M | -42.33M | 163.94M |
| Total operating expenses | -71.89M | -41.01M | -38.66M | -26.32M | -548.23M | -892.55M | -1.03B | -1.26B | -1.27B | -1.35B | -1.09B | -1.02B |
| Prepaid expenses | 4.44M | 3.84M | 2.75M | 702.00K | 635.00K | 1.33M | 3.20M | 2.62M | 3.15M | 1.42M | 1.31M | 2.15M |
| Deferred income, current | 127.55K | 1.18M | 23.32K | 23.00K | 468.00K | — | — | 6.14M | 16.99M | 23.07M | 15.03M | 37.92M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.84M | 2.76M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 4.00M | 3.75M | 3.80M | 3.36M | — | 8.92M | — | 11.92M | 15.73M | 18.70M | 19.69M | 21.11M |
| Deferred income, non-current | 295.53K | 174.78K | 0 | — | — | 40.96M | 43.59M | 28.47M | 23.47M | 18.48M | 13.47M | 8.48M |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | — | — | — | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800